The project will be divided into two campuses: the Clínic Campus, located on the premises of Hospital Clínic de Barcelona; the UB Faculty of Medicine and the CIBEK research center; and the Germans Trias i Pujol Campus, located on the premises of Hospital Universitari Germans Trias i Pujol, the UB Faculty of Medicine and other research centers. The new institution will be located in a 4000-m2 building that will be built on the Germans Trias i Pujol campus. Construction and equipment will have a budget of €9,000,000. Furthermore, the institute will establish collaboration agreements with other research centers both in Catalonia and in the rest of Spain and abroad. The Catalan government has committed to an annual contribution sufficient to ensure the operation of the institute, which will consist of 100 collaborators divided into 8-10 research teams. The operating budget will be €5,000,000 per year, including the funding from the Catalan government and funding obtained from grants, subsidies and sponsorship.
The Josep Carreras Foundation Sponsors a New Research Institute on Leukemia
.
An agreement of intentions signed this afternoon at the Catalan Government Palace presented the new International Research Institute on Leukemia (Institut Internacional de Recerca contra la Leucèmia), linked to the Josep Carreras Foundation. Taking part in the action were the President of the Catalan Government, José Montilla, the tenor Josep Carreras, the Catalan Minister for Health, Marina Geli, the Catalan Minister for Innovation, Universities and Enterprise, Josep Huguet and the Mayor of Badalona, Jordi Serra. Hospital Clínic de Barcelona and Hospital Germans Trias i Pujol, together with the Josep Carreras Foundation and the Catalan Government, will be the main sponsors of this initiative.
The new institute will be the first Spanish center, and one of only a few worldwide, dedicated exclusively to research on malignant blood diseases. The initiative is the result of three great efforts: the personal will of the tenor Josep Carreras, whose foundation has been fighting leukemia for more than 20 years; the excellent Catalan scientific standard in the field of hematology; and the support of the Catalan government in consolidating Catalonia as a pioneer in biotechnology and biomedicine.
